Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-24-018671

Chief Scientific Officer sold 118,922 shares at $55.00 ($6,540,710)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Reich Kristian Chief Scientific Officer 2024-02-27 Sale 10b5-1 −29,491 $55.00 $1,622,005 2,957,483 I
Reich Kristian Chief Scientific Officer 2024-02-27 Sale 10b5-1 −29,431 $55.00 $1,618,705 70,071 D
Reich Kristian Chief Scientific Officer 2024-02-28 Sale 10b5-1 −31,910 $55.00 $1,755,050 2,925,573 I
Reich Kristian Chief Scientific Officer 2024-02-28 Sale 10b5-1 −28,090 $55.00 $1,544,950 41,981 D
Open-market sales · 118,922 sh · avg $55.00 · $6,540,710
Loading xslF345X05/ownership.xml…